title: [Pseudomembranous colitis caused by antibiotic therapy. Results of a survey of the patient material from the praxis of 900 gastroenterologists].
abstract: A retrospective study conducted by interviewing French gastroenterologists was performed with the objective of evaluating the incidence and etiology of pseudomembranous colitis in cases where the diagnosis has been confirmed by coloscopy. This study allowed to collect data on 878 pseudomembranous colitis observed by 438 gastroenterologists within 6 months. It shows evidence of the importance of various antibiotics in the etiology of pseudomembranous colitis (89% of the identified cases). The following is the list of antibiotics or antibiotic classes, in increasing order of their association with the development of pseudomembranous colitis: macrolides which are very rarely associated, a group represented by cefaclor, cefuroxime axetil and cyclins, which are rarely associated, a third group constituted by amoxicillin, ofloxacin and trimethoprim-sulfamethoxazole which appears to be 2 to 3 times more frequently associated than the previous group, and a fourth group of antibiotics, represented by cefixime and the association amoxicillin-clavulanic acid, which is 7 times more frequently associated than antibiotics of the second group.
authors.affiliation: Hôpital Bichat, Paris.
authors.forename: C
authors.initials: C
authors.lastname: Carbon
authors.forename: A
authors.initials: A
authors.lastname: Richard
authors.forename: B
authors.initials: B
authors.lastname: Bons
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000145:classification; D002648:Child; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced / Q000453:epidemiology*; D005260:Female; D005602:France / Q000453:epidemiology; D005762:Gastroenterology / Q000706:statistics & numerical data; D006306:Health Surveys; D006801:Humans; D008297:Male; D012189:Retrospective Studies
chemical_list: D000900:Anti-Bacterial Agents
vernacular_title: Les colites pseudo-membraneuses associées à l'antibiothérapie. Résultats d'une enquête auprès de 900 gastroentérologues.